These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 8242596)

  • 1. Translocation (2;4)(p23;q25): an additional case of a new recurrent anomaly in acute myeloid leukemia.
    Shi G; Weh HJ; Hossfeld DK
    Cancer Genet Cytogenet; 1993 Oct; 70(2):140-1. PubMed ID: 8242596
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Novel translocation (2;4) with consistent involvement of 2p23 in acute nonlymphocytic leukemia (M2).
    Farag S; Challis J; White J; Garson OM
    Cancer Genet Cytogenet; 1992 Jan; 58(1):48-51. PubMed ID: 1728949
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Translocation (12;15)(p13;q13) in a patient with relapsed acute myeloid leukemia.
    Lim SW; Falk RE; Look RM; Fuerst MM; Lawrence GN; Kusuanco DA; Giles FJ
    Cancer Genet Cytogenet; 1996 Feb; 86(2):165-7. PubMed ID: 8603347
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Translocation (9;17) a novel translocation in acute myeloid leukaemia.
    Brown SA; Czepulkowski B; Ireland R
    Leuk Res; 1996; 20(11-12):987-8. PubMed ID: 9009258
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [The detection of minimal residual disease by DEK/CAN chimeric m-RNA in a case of AML M2 with translocation t(6;9) (p23;q34) after chemotherapy and peripheral blood stem cell transplantation].
    Toyosawa M; Shinohara K; Ariyoshi K; Ando T; Kobayashi M; Hikiji K
    Rinsho Ketsueki; 1997 Jan; 38(1):33-40. PubMed ID: 9028159
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Marked bone marrow eosinophilia at the time of relapse of acute myeloblastic leukaemia in association with the appearance of translocation t(12;20)(q24;q11).
    Partridge F; Richardson W; Kearns P; Wilcox R; Majumdar G
    Leuk Lymphoma; 1996 Jun; 22(1-2):181-2. PubMed ID: 8724547
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Two additional cases of acute myeloid leukemia with t(7;11)(p15;p15) having low neutrophil alkaline phosphatase scores.
    Fujimura T; Ohyashiki K; Ohyashiki JH; Kawakubo K; Iwabuchi A; Kodama A; Toyama K
    Cancer Genet Cytogenet; 1993 Jul; 68(2):143-6. PubMed ID: 8353806
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Acute myelogenous leukemia associated with Ollier disease.
    White MS; Martin PL; McLean TW
    Pediatr Blood Cancer; 2008 Mar; 50(3):645-6. PubMed ID: 16991136
    [TBL] [Abstract][Full Text] [Related]  

  • 9. De novo acute myelogenous leukemia with trilineage myelodysplasia associated with t(8;21)(q22;q22).
    Fujisawa S; Togawa J; Tanaka M; Koharazawa H; Aoba M; Fujita H; Murata T; Kanamori H; Matsuzaki M; Mohri H; Ishigatsubo Y
    Intern Med; 1999 Jul; 38(7):607-11. PubMed ID: 10435370
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Complex chromosome 8;21 translocation with associated hyperdiploidy in acute myeloid leukemia (FAB-M2).
    Corral Mdel P; Villa O; Alfaro EM; Alonso CN; Baro C; Felice MS; Rossi J; Solé F; Gallego MS
    Pediatr Blood Cancer; 2008 Mar; 50(3):651-4. PubMed ID: 17405156
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Acquired acute myelogenous leukemia after therapy for acute promyelocytic leukemia with t(15;17): a case report and review of the literature.
    Betancourt-García RD; Castro J; Fernández AC; López-Enríquez A; Fradera J; Pacheco E
    P R Health Sci J; 2009 Jun; 28(2):146-50. PubMed ID: 19530558
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A third case of apparent t(2;4)(p23;q25) represents ins(2;4) with deletion of 2p.
    Richkind KE; Lamb A; Lytle C; Velasco J
    Leukemia; 1996 Nov; 10(11):1847. PubMed ID: 8892694
    [No Abstract]   [Full Text] [Related]  

  • 13. High-dose cytarabine in induction treatment improves the outcome of adult patients younger than age 46 years with acute myeloid leukemia: results of the EORTC-GIMEMA AML-12 trial.
    Willemze R; Suciu S; Meloni G; Labar B; Marie JP; Halkes CJ; Muus P; Mistrik M; Amadori S; Specchia G; Fabbiano F; Nobile F; Sborgia M; Camera A; Selleslag DL; Lefrère F; Magro D; Sica S; Cantore N; Beksac M; Berneman Z; Thomas X; Melillo L; Guimaraes JE; Leoni P; Luppi M; Mitra ME; Bron D; Fillet G; Marijt EW; Venditti A; Hagemeijer A; Mancini M; Jansen J; Cilloni D; Meert L; Fazi P; Vignetti M; Trisolini SM; Mandelli F; de Witte T
    J Clin Oncol; 2014 Jan; 32(3):219-28. PubMed ID: 24297940
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Trisomy 21 with t(5; 11) chromosomal translocation as new unfavorable cytogenetic abnormalities in pediatric acute myeloid leukemia type M2: One case report of nine-year follow-up and literature review.
    Wang L; Wu XY; Jin RM; Zhang BY; Qiu YN
    J Huazhong Univ Sci Technolog Med Sci; 2017 Oct; 37(5):807-810. PubMed ID: 29058300
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Concomitant t(4;11) and t(1;19) in a patient with biphenotypic acute leukemia.
    Gozzetti A; Calabrese S; Raspadori D; Crupi R; Tassi M; Bocchia M; Fabbri A; Lauria F
    Cancer Genet Cytogenet; 2007 Aug; 177(1):81-2. PubMed ID: 17693199
    [No Abstract]   [Full Text] [Related]  

  • 16. Complex t(2;21;8)(p12;q22;q22): a variant t(8;21) in a patient with acute myeloid leukemia (AML-M2).
    Wang H; Yang W; Shao H; Zhang J; Qi L; Liao A; Li Y; Liu Z
    Cancer Genet Cytogenet; 2009 Jan; 188(2):95-8. PubMed ID: 19100512
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Unexpected pancytopenia following treatment of acute lymphoblastic leukemia.
    Innes A; May PC; Pavlů J; Bain BJ
    Am J Hematol; 2012 Apr; 87(4):412. PubMed ID: 21953481
    [No Abstract]   [Full Text] [Related]  

  • 18. Jumping translocation involving 1q21 during long-term complete remission of acute myeloid leukemia.
    Nagai S; Nannya Y; Takahashi T; Kurokawa M
    Ann Hematol; 2010 Jul; 89(7):741-2. PubMed ID: 19904535
    [No Abstract]   [Full Text] [Related]  

  • 19. Clinical Impact of Additional Cytogenetic Aberrations, cKIT and RAS Mutations, and Treatment Elements in Pediatric t(8;21)-AML: Results From an International Retrospective Study by the International Berlin-Frankfurt-Münster Study Group.
    Klein K; Kaspers G; Harrison CJ; Beverloo HB; Reedijk A; Bongers M; Cloos J; Pession A; Reinhardt D; Zimmerman M; Creutzig U; Dworzak M; Alonzo T; Johnston D; Hirsch B; Zapotocky M; De Moerloose B; Fynn A; Lee V; Taga T; Tawa A; Auvrignon A; Zeller B; Forestier E; Salgado C; Balwierz W; Popa A; Rubnitz J; Raimondi S; Gibson B
    J Clin Oncol; 2015 Dec; 33(36):4247-58. PubMed ID: 26573082
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Unfavourable outcome of a patient with M2 acute non lymphocytic leukemia and a 47,XY,t(5;7)(q34;q21), +8 karyotype.
    Testoni N; Zaccaria A; Celso B; Tura S
    Haematologica; 1991; 76(1):65-8. PubMed ID: 2055562
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.